ISSN (Print):
ISSN (Online):

Current Drug Targets - CNS & Neurological Disorders

(Continued as CNS & Neurological Disorders - Drug Targets)

Impact Factor: 2.628

Volume 4 , Issues 6, 2005

Impact Factor
Web of Science Impact Factor

Current: 2.628
5 - Year: 3.148

Ranking & Category

  • 107th of 254 in Pharmacology & Pharmacy

Topic(s) Covered

1 Topic(s)


Aims & Scope

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.

CNS & Neurological Disorders - Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts for publication original research articles, letters, reviews and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Abstracted & Indexed in:


"This journal is the definitive source for the most meaningful and critical information available on CNS drug targets and progress both in industrial and academic based neurodegeneration research."

Rudolf E. Tanzi
Harvard Medical School, USA

© 2024 Bentham Science Publishers | Privacy Policy